Neonc Technologies Holdings, Inc. (NASDAQ: NTHI) is a Healthcare company (Biotechnology) with a market capitalization of $125M. The Maz Rating grades it against the other companies in its sector.
Neonc Technologies Holdings, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
Neonc Technologies Holdings, Inc. has been loss-making over the last twelve months, so it has no meaningful P/E. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of 349.3%, return on invested capital of 316.1% and a free cash flow yield of -16.4%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 0.38. Over the past 52 weeks the share price ranged from $2.50 to $11.38, with a beta of 0.50.
Neonc Technologies Holdings, Inc. does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.